Quarterly report pursuant to Section 13 or 15(d)

REVENUE (Details Narrative)

v3.24.3
REVENUE (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Jan. 01, 2023
Disaggregation of Revenue [Line Items]            
Revenue $ 28,546,000 $ 29,280,000 $ 82,598,000 $ 88,643,000    
Amortization of deferred sales commissions 79,000 105,000 252,000 389,000    
Accumulated deficit (69,926,000)   (69,926,000)   $ (74,481,000)  
Trade Accounts Receivable [Member] | Accounting Standards Update 2016-13 [Member]            
Disaggregation of Revenue [Line Items]            
Accumulated deficit           $ 186,000
Other Noncurrent Assets [Member]            
Disaggregation of Revenue [Line Items]            
Deferred commissions 443,000 543,000 443,000 543,000    
Chronic Care Management [Member]            
Disaggregation of Revenue [Line Items]            
Revenue 929,000 440,000 2,200,000 914,000    
Remote Patient Monitoring [Member]            
Disaggregation of Revenue [Line Items]            
Revenue 194,000 $ 183,000 544,000 262,000    
Professional Services [Member] | Unbilled Revenues [Member]            
Disaggregation of Revenue [Line Items]            
Revenue     88,000 $ 243,000    
Revenue Cycle Management [Member]            
Disaggregation of Revenue [Line Items]            
Revenue, remaining performance obligation, amount 3,800,000   3,800,000      
Group Purchasing Services [Member]            
Disaggregation of Revenue [Line Items]            
Contract with customer asset 543,000   543,000      
Referral Fees [Member]            
Disaggregation of Revenue [Line Items]            
Contract with customer asset $ 294,000   $ 294,000